Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Reltecimod TFA
Reltecimod TFA
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-1026 | 50mg | 200.00 | + Add to cart |
|
| R-R-1026 | 250mg | 750.00 | + Add to cart |
|
|
|
||||
Product description
Reltecimod (AB-103) TFA is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod TFA has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod TFA modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod TFA can be used to research necrotizing soft-tissue infections (NSTIs).
| Appearance | N/A |
|---|---|
| Molecular Weight | 1037.19 |
| Purity | >90% |
| Sequence | Ala-Ser-Pro-Met-Leu-Val-Ala-Tyr-Asp-Ala |
| Formula | C46H72N10O15S.xC2HF3O2 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds of Reltecimod TFA Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
